Reaction Details |
| Report a problem with these data |
Target | Nuclear receptor subfamily 4 group A member 2 |
---|
Ligand | BDBM50517811 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_1869815 (CHEMBL4370881) |
---|
EC50 | 45±n/a nM |
---|
Citation | Lesuisse, D; Malanda, A; Peyronel, JF; Evanno, Y; Lardenois, P; De-Peretti, D; Abécassis, PY; Barnéoud, P; Brunel, P; Burgevin, MC; Cegarra, C; Auger, F; Dommergue, A; Lafon, C; Even, L; Tsi, J; Luc, TPH; Almario, A; Olivier, A; Castel, MN; Taupin, V; Rooney, T; Vigé, X Development of a novel NURR1/NOT agonist from hit to lead and candidate for the potential treatment of Parkinson's disease. Bioorg Med Chem Lett29:929-932 (2019) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Nuclear receptor subfamily 4 group A member 2 |
---|
Name: | Nuclear receptor subfamily 4 group A member 2 |
Synonyms: | NOT | NR4A2 | NR4A2_HUMAN | NURR1 | TINUR |
Type: | PROTEIN |
Mol. Mass.: | 66603.77 |
Organism: | Homo sapiens (Human) |
Description: | ChEMBL_453027 |
Residue: | 598 |
Sequence: | MPCVQAQYGSSPQGASPASQSYSYHSSGEYSSDFLTPEFVKFSMDLTNTEITATTSLPSF
STFMDNYSTGYDVKPPCLYQMPLSGQQSSIKVEDIQMHNYQQHSHLPPQSEEMMPHSGSV
YYKPSSPPTPTTPGFQVQHSPMWDDPGSLHNFHQNYVATTHMIEQRKTPVSRLSLFSFKQ
SPPGTPVSSCQMRFDGPLHVPMNPEPAGSHHVVDGQTFAVPNPIRKPASMGFPGLQIGHA
SQLLDTQVPSPPSRGSPSNEGLCAVCGDNAACQHYGVRTCEGCKGFFKRTVQKNAKYVCL
ANKNCPVDKRRRNRCQYCRFQKCLAVGMVKEVVRTDSLKGRRGRLPSKPKSPQEPSPPSP
PVSLISALVRAHVDSNPAMTSLDYSRFQANPDYQMSGDDTQHIQQFYDLLTGSMEIIRGW
AEKIPGFADLPKADQDLLFESAFLELFVLRLAYRSNPVEGKLIFCNGVVLHRLQCVRGFG
EWIDSIVEFSSNLQNMNIDISAFSCIAALAMVTERHGLKEPKRVEELQNKIVNCLKDHVT
FNNGGLNRPNYLSKLLGKLPELRTLCTQGLQRIFYLKLEDLVPPPAIIDKLFLDTLPF
|
|
|
BDBM50517811 |
---|
n/a |
---|
Name | BDBM50517811 |
Synonyms: | CHEMBL4576867 |
Type | Small organic molecule |
Emp. Form. | C20H15ClN2O |
Mol. Mass. | 334.799 |
SMILES | OCc1cccc(c1)-c1ccc2nc(cn2c1)-c1ccc(Cl)cc1 |
Structure |
|